北米のシリンジ輸液ポンプ市場規模、シェア、動向分析レポート：適応疾患別、最終用途別、国別、セグメント別予測、2025年～2030年

北米のシリンジ輸液ポンプ市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、北米のシリンジ輸液ポンプ市場規模は2030年までに10億4,000万米ドルに達すると予測され、2025年から2030年までのCAGRは8.4%で成長する見込みです。

同市場は、成人の約10人に6人が罹患している慢性疾患の有病率の増加や、がんや糖尿病などの疾患に対する正確で継続的な薬物投与が必要とされていることが、大幅な成長の原動力となっています。

外科手術やICU入室の増加により、麻酔薬や重症治療薬の投与に不可欠なポンプへの需要がさらに高まっています。これは、米国の入院件数が2025年の3,600万件から2035年には4,000万件に増加すると予測されていることを考えると、特に当てはまる。

投与エラー削減システム（DERS）や電子カルテとの互換性を含むスマート輸液技術の技術的進歩は、北米がその採用でリードしているように、投薬の安全性と効率を高める上で極めて重要です。高齢化とコスト抑制戦略に後押しされて拡大する在宅ヘルスケアと外来ケア分野は、病院外での安全な投薬のために、携帯可能で使いやすいシリンジポンプの需要を高めています。良好な規制環境と償還政策が、市場の持続的成長と技術革新をさらに後押ししています。

北米シリンジ注入ポンプ市場レポート・ハイライト

• 小児科/新生児科が2024年に25.0%以上の最大売上シェアを占めました。これは、新生児や乳児に対する正確なドラッグデリバリーの重要なニーズと、安全技術の進歩やNICU/PICUへの投資によるものです。
• 化学療法分野は、予測期間中に最も速いCAGRで成長すると予測されています。
• 市場成長の原動力は、安全性に支えられた強力なドラッグの正確なシリンジポンプデリバリーに対する重要なニーズと、がん患者の増加です。
• 病院は、クリティカルケアや多様な用途における正確なドラッグデリバリーへの高い需要により、2024年の総売上シェアの約40.0％を占め、市場を独占しています。
• ホームケアは予測期間中最も速いCAGR 8.7％で成長すると予測されます。
• 北米のシリンジ輸液ポンプ市場は、慢性疾患の高い有病率と国民医療費の増加に支えられ、米国が圧倒的なシェアを占めました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 北米のシリンジ輸液ポンプ市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 北米シリンジ輸液ポンプ市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 北米のシリンジ輸液ポンプ市場：疾患疾患別　推定・動向分析

• 疾患適応セグメントダッシュボード
• 北米シリンジ輸液ポンプ市場：疾患適応症変動分析
• 北米シリンジ輸液ポンプ市場規模と動向分析（疾患別、2018～2030年）
• 化学療法
• 糖尿病
• 消化器内科
• 鎮痛/疼痛管理
• 小児科・新生児科
• 血液内科
• その他

第5章 北米のシリンジ輸液ポンプ市場：最終用途別　推定・動向分析

• 最終用途セグメントダッシュボード
• 北米シリンジ輸液ポンプ市場：最終用途変動分析
• 北米シリンジ輸液ポンプ市場規模と動向分析（最終用途別、2018～2030年）
• 病院
• ホームケア
• その他（ASC、介護施設、リハビリテーションセンター）

第6章 北米のシリンジ輸液ポンプ市場：国別　推定・動向分析

• 国別市場ダッシュボード
• 国別市場シェア分析、2024年および2030年
• 北米シリンジ輸液ポンプ市場（国別）：主なポイント
• 米国
  • 主要国の動向
  • 規制枠組み/償還構造
  • 競合シナリオ
• カナダ
  • 主要国の動向
  • 規制枠組み/償還構造
  • 競合シナリオ
• メキシコ
  • 主要国の動向
  • 規制枠組み/償還構造
  • 競合シナリオ

第7章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
• ベンダー情勢
  • 主要企業のヒートマップ分析、2024年
• 企業プロファイル
  • Baxter
  • B. Braun Medical Inc.
  • Fresenius Kabi AG
  • ICU Medical, Inc.
  • Micrel Medical Devices SA
  • Boston Scientific Corporation
  • BD
  • Terumo Corporation
  • Moog Inc.
  • IRadimed Corporation
  • CODAN Companies
  • ACROMED

List of Tables

• Table 1 List of abbreviations
• Table 2 North America syringe infusion pumps market, by country, 2018 - 2030 (USD Million)
• Table 3 North America syringe infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
• Table 4 North America syringe infusion pumps market, by end use, 2018 - 2030 (USD Million)
• Table 5 U.S. syringe infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
• Table 6 U.S. syringe infusion pumps market, by end use, 2018 - 2030 (USD Million)
• Table 7 Canada syringe infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
• Table 8 Canada syringe infusion pumps market, by end use, 2018 - 2030 (USD Million)
• Table 9 Mexico syringe infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
• Table 10 Mexico surgical ablation market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Primary interviews
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 North America syringe infusion pumps market: market outlook
• Fig. 10 North America syringe infusion pumps competitive insights
• Fig. 11 Parent market outlook
• Fig. 12 Related/ancillary market outlook
• Fig. 13 Penetration and growth prospect mapping
• Fig. 14 Industry value chain analysis
• Fig. 15 North America syringe infusion pumps market driver impact
• Fig. 16 North America syringe infusion pumps market restraint impact
• Fig. 17 North America syringe infusion pumps market strategic initiatives analysis
• Fig. 18 North America syringe infusion pumps market: Disease indication movement analysis
• Fig. 19 North America syringe infusion pumps market: Disease indication outlook and key takeaways
• Fig. 20 Chemotherapy estimates and forecast, 2018 - 2030
• Fig. 21 Diabetes estimates and forecast, 2018 - 2030
• Fig. 22 Gastroenterology estimates and forecast, 2018 - 2030
• Fig. 23 Analgesia/Pain management estimates and forecast, 2018 - 2030
• Fig. 24 Pediatrics/Neonatology estimates and forecast, 2018 - 2030
• Fig. 25 Hematology estimates and forecast, 2018 - 2030
• Fig. 26 Others estimates and forecast, 2018 - 2030
• Fig. 27 North America syringe infusion pumps market: End use movement analysis
• Fig. 28 North America syringe infusion pumps market: End use outlook and key takeaways
• Fig. 29 Hospitals estimates and forecast, 2018 - 2030
• Fig. 30 Homecare estimates and forecast, 2018 - 2030
• Fig. 31 Others (ASC, nursing homes, rehabilitation centers) estimates and forecast, 2018 - 2030
• Fig. 32 North America syringe infusion pumps market: Country movement analysis
• Fig. 33 North America syringe infusion pumps market: Country outlook and key takeaways
• Fig. 34 U.S. market estimates and forecasts, 2018 - 2030
• Fig. 35 Canada market estimates and forecasts, 2018 - 2030
• Fig. 36 Mexico market estimates and forecasts, 2018 - 2030

North America Syringe Infusion Pumps Market Growth and Trends:

The North America syringe infusion pumps market size is anticipated to reach USD 1.04 billion by 2030 and is expected to grow at a CAGR of 8.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is experiencing substantial growth driven by the increasing prevalence of chronic diseases, affecting approximately six in ten adults and necessitating precise, continuous medication delivery for conditions such as cancer and diabetes.

The rising number of surgical procedures and ICU admissions further amplifies demand for these pumps, crucial for delivering anesthetics and critical care medications. This is especially true considering the projected increase in U.S. hospitalizations from 36 million in 2025 to 40 million by 2035.

Technological advancements in smart infusion technologies, including Dose Error Reduction Systems (DERS) and EHR compatibility, are pivotal in enhancing medication safety and efficiency, as North America leads in their adoption. The expanding home healthcare and ambulatory care sectors, fueled by an aging population and cost-containment strategies, are increasing the demand for portable, user-friendly syringe pumps for safe medication delivery outside hospitals. Favorable regulatory environments and reimbursement policies further support the sustained growth and innovation within the market.

North America Syringe Infusion Pumps Market Report Highlights:

• Pediatrics/neonatology held the largest revenue share of over 25.0% in 2024, owing to the critical need for precise drug delivery for newborns and infants, coupled with advancements in safety technologies and NICU/PICU investments
• The chemotherapy segment is projected to grow at the fastest CAGR over the forecast period
• Market growth is fueled by the critical need for precise syringe pump delivery of potent drugs, supported by safety features, and the increasing number of cancer cases.
• Hospitals dominated the market with around 40.0% of the total revenue share in 2024 due to high demand for precise drug delivery in critical care and diverse applications.
• Homecare is projected to grow at the fastest CAGR of 8.7% over the forecast period.
• The U.S. dominated the North American syringe infusion pumps market, supported by the high prevalence of chronic diseases and growing national healthcare expenditure.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Disease Indication
  • 1.2.2. End Use
  • 1.2.3. Country scope
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Disease indication outlook
  • 2.2.2. End use outlook
  • 2.2.3. Country outlook
• 2.3. Competitive Insights

Chapter 3. North America Syringe Infusion Pumps Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. North America Syringe Infusion Pumps Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. North America Syringe Infusion Pumps Market: Disease Indication Estimates & Trend Analysis

• 4.1. Disease Indication Segment Dashboard
• 4.2. North America Syringe Infusion Pumps Market: Disease Indication Movement Analysis
• 4.3. North America Syringe Infusion Pumps Market Size & Trend Analysis, by Disease Indication, 2018 to 2030 (USD Million)
• 4.4. Chemotherapy
  • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Diabetes
  • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Gastroenterology
  • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.7. Analgesia/Pain Management
  • 4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.8. Pediatrics/Neonatology
  • 4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.9. Hematology
  • 4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.10. Others
  • 4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. North America Syringe Infusion Pumps Market: End Use Estimates & Trend Analysis

• 5.1. End Use Segment Dashboard
• 5.2. North America Syringe Infusion Pumps Market: End Use Movement Analysis
• 5.3. North America Syringe Infusion Pumps Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 5.4. Hospitals
  • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Homecare
  • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Others (ASC, Nursing Homes, Rehabilitation Centers)
  • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. North America Syringe Infusion Pumps Market: Country Estimates & Trend Analysis

• 6.1. Country Market Dashboard
• 6.2. Country Market Share Analysis, 2024 & 2030
• 6.3. North America Syringe Infusion Pumps Market by country: Key Takeaways
• 6.4. U.S.
  • 6.4.1. Key country dynamics
  • 6.4.2. Regulatory framework/ reimbursement structure
  • 6.4.3. Competitive scenario
  • 6.4.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Canada
  • 6.5.1. Key country dynamics
  • 6.5.2. Regulatory framework/ reimbursement structure
  • 6.5.3. Competitive scenario
  • 6.5.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Mexico
  • 6.6.1. Key country dynamics
  • 6.6.2. Regulatory framework/ reimbursement structure
  • 6.6.3. Competitive scenario
  • 6.6.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Vendor Landscape
  • 7.3.1. Key company heat map analysis, 2024
• 7.4. Company Profiles
  • 7.4.1. Baxter
    • 7.4.1.1. Company overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Product benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. B. Braun Medical Inc.
    • 7.4.2.1. Company overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Product benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. Fresenius Kabi AG
    • 7.4.3.1. Company overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Product benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. ICU Medical, Inc.
    • 7.4.4.1. Company overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Product benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. Micrel Medical Devices SA
    • 7.4.5.1. Company overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Product benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. Boston Scientific Corporation
    • 7.4.6.1. Company overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Product benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. BD
    • 7.4.7.1. Company overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Product benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. Terumo Corporation
    • 7.4.8.1. Company overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Product benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. Moog Inc.
    • 7.4.9.1. Company overview
    • 7.4.9.2. Financial performance
    • 7.4.9.3. Product benchmarking
    • 7.4.9.4. Strategic initiatives
  • 7.4.10. IRadimed Corporation
    • 7.4.10.1. Company overview
    • 7.4.10.2. Financial performance
    • 7.4.10.3. Product benchmarking
    • 7.4.10.4. Strategic initiatives
  • 7.4.11. CODAN Companies
    • 7.4.11.1. Company overview
    • 7.4.11.2. Financial performance
    • 7.4.11.3. Product benchmarking
    • 7.4.11.4. Strategic initiatives
  • 7.4.12. ACROMED
    • 7.4.12.1. Company overview
    • 7.4.12.2. Financial performance
    • 7.4.12.3. Product benchmarking
    • 7.4.12.4. Strategic initiatives